Lancaster General Ann B Barshinger Cancer Institute is a clinical research site located in Lancaster, Pennsylvania, United States 17601.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
Lancaster General Ann B Barshinger Cancer Institute has participated in 22 clinical trials with 19 currently active.
Therapeutic areas: Gliosarcoma, MGMT-Unmethylated Glioblastoma, Advanced Esophageal Adenocarcinoma.
Sponsors: National Cancer Institute (NCI), NRG Oncology, Lancaster General Hospital.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Lancaster
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lancaster General Ann B Barshinger Cancer Institute has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lancaster General Ann B Barshinger Cancer Institute has 22 clinical trials on record, with 19 currently active. Their work covers Gliosarcoma, MGMT-Unmethylated Glioblastoma, Advanced Esophageal Adenocarcinoma.
Lancaster General Ann B Barshinger Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.